Literature DB >> 18000964

Atypical antipsychotics in severe anorexia nervosa in children and adolescents--review and case reports.

Claudia Mehler-Wex1, Marcel Romanos, Julia Kirchheiner, Ulrike M E Schulze.   

Abstract

OBJECTIVE: To review the literature on the use of atypical antipsychotics in anorexia nervosa of children and adolescents and to present three case reports on quetiapine treatment of this subgroup.
METHOD: Review of the literature and case report.
RESULTS: Several case reports and two small open-label trials, mainly in adults, observed beneficial effects of olanzapine on anorexic psychopathology. Only 16 case reports have been published on children and adolescents. Because of its lower propensity to induce weight gain quetiapine might be favourable with regard to patients' compliance. Our case reports revealed positive psychopathological effects and good tolerability of quetiapine in minors with severe anorexia nervosa. Careful titration and intense drug monitoring are recommended. DISCUSSION: In a small subset of patients with severe, treatment- resistant anorexia nervosa, extreme weight phobia, delusional body image disturbances or severe hyperactivity might be considered as indications for atypical antipsychotics. However, controlled studies are needed. (c) 2007 John Wiley & Sons, Ltd and Eating Disorders Association

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18000964     DOI: 10.1002/erv.843

Source DB:  PubMed          Journal:  Eur Eat Disord Rev        ISSN: 1072-4133


  7 in total

1.  Olanzapine use for the adjunctive treatment of adolescents with anorexia nervosa.

Authors:  Mark L Norris; Wendy Spettigue; Annick Buchholz; Katherine A Henderson; Rebecca Gomez; Danijela Maras; Isabelle Gaboury; Andy Ni
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-04-21       Impact factor: 2.576

Review 2.  Anorexia nervosa.

Authors:  Kathleen Kara Fitzpatrick; James Lock
Journal:  BMJ Clin Evid       Date:  2011-04-11

3.  Differential weight restoration on olanzapine versus fluoxetine in identical twins with anorexia nervosa.

Authors:  Vikas Duvvuri; Taya Cromley; Megan Klabunde; Kerri Boutelle; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2011-02-22       Impact factor: 4.861

Review 4.  Transient psychosis in anorexia nervosa: review and case report.

Authors:  S Sarró
Journal:  Eat Weight Disord       Date:  2009 Jun-Sep       Impact factor: 4.652

Review 5.  Canadian practice guidelines for the treatment of children and adolescents with eating disorders.

Authors:  Jennifer Couturier; Leanna Isserlin; Mark Norris; Wendy Spettigue; Melissa Brouwers; Melissa Kimber; Gail McVey; Cheryl Webb; Sheri Findlay; Neera Bhatnagar; Natasha Snelgrove; Amanda Ritsma; Wendy Preskow; Catherine Miller; Jennifer Coelho; Ahmed Boachie; Cathleen Steinegger; Rachel Loewen; Techiya Loewen; Elizabeth Waite; Catherine Ford; Kerry Bourret; Joanne Gusella; Josie Geller; Adele LaFrance; Anick LeClerc; Jennifer Scarborough; Seena Grewal; Monique Jericho; Gina Dimitropoulos; David Pilon
Journal:  J Eat Disord       Date:  2020-02-01

Review 6.  Perplexities of treatment resistance in eating disorders.

Authors:  Katherine A Halmi
Journal:  BMC Psychiatry       Date:  2013-11-07       Impact factor: 3.630

7.  Survey on self-reported psychotropic drug prescribing practices of eating disorder psychiatrists for the treatment of young people with anorexia nervosa.

Authors:  Maedeh Y Beykloo; Dasha Nicholls; Mima Simic; Ruth Brauer; Elizabeth Mills; Ian C K Wong
Journal:  BMJ Open       Date:  2019-09-20       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.